SMTL ID : 3rx4.1

Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 31 residues within 4Å: Chain A: G.39, T.40, W.41, K.42, D.64, Y.69, K.98, H.131, S.180, N.181, Q.204, Y.230, S.231, P.232, L.233, G.234, S.235, P.236, D.237, A.266, I.281, P.282, K.283, S.284, V.285, T.286, R.289, E.292, N.293, C.319 Ligands: SFI.2 32 PLIP interactions: 32 interactions with chain A Hydrophobic interactions: A:W.41 Hydrogen bonds: A:T.40, A:W.41, A:D.64, A:D.64, A:Y.69, A:S.180, A:N.181, A:Q.204, A:S.231, A:L.233, A:G.234, A:S.235, A:S.235, A:D.237, A:D.237, A:K.283, A:S.284, A:V.285, A:T.286, A:T.286, A:E.292, A:N.293 Water bridges: A:R.289, A:R.289, A:R.289, A:R.289 Salt bridges: A:K.42, A:K.283, A:R.289 pi-Stacking: A:Y.230 pi-Cation interactions: A:R.289

1 x SFI: 2-[(3Z)-6-fluoranyl-2-methyl-3-[(4-methylsulfanylphenyl)methylidene]inden-1-yl]ethanoic acid(Non-covalent)

SFI.2: 11 residues within 4Å: Chain A: W.41, V.68, Y.69, H.131, W.132, F.143, W.240, C.319, L.321, S.323 Ligands: NAP.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.41, A:F.143, A:F.143, A:F.143, A:W.240, A:L.321 Salt bridges: A:H.131 Halogen bonds: A:V.68

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zheng, X. et al., The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase. Febs Lett. (2012)

Release Date

2011-11-30

Peptides

Aldose reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aldose reductase

Related Entries With Identical Sequence